Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Multiple sclerosis reactivation postfingolimod cessation: Is it IRIS?
Teva and Active Biotech Announce Expansion of Laquinimod Clinical Development Program with New Trial in Primary Progressive Multiple Sclerosis and First Patient Screened in Huntington's Disease Trial
Natalizumab exerts a suppressive effect on surrogates of B cell function in blood and CSF.
Age-specific sex ratio of multiple sclerosis in the National Swedish MS Register (SMSreg).
Diffusion-weighted imaging characteristics of biopsy-proven demyelinating brain lesions.
Journal Club: Intrathecal effects of daclizumab treatment of multiple sclerosis.
[Sphingosine-1-phosphate signaling system and the innovative mechanism of action of fingolimod in treatment of multiple sclerosis: review of foreign literature.]
Papaverine inhibits lipopolysaccharide-induced microglial activation by suppressing NF-κB signaling pathway.
Role of the innate and adaptive immune responses in the course of multiple sclerosis.
Prognostic factors of acute partial transverse myelitis.
The Symptom Inventory Disability-Specific Short Forms for Multiple Sclerosis: Construct Validity, Responsiveness, and Interpretation.
CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation.
[The role of brain glucose metabolism in the development of cognitive dysfunctions in patients with remitting and secondary-progressive multiple sclerosis.]
Shape Analysis of the Corpus Callosum and Cerebellum in Female MS Patients with Different Clinical Phenotypes.
Sexual Behavior, Body Image, and Partnership in Chronic Illness: A Comparison of Huntington's Disease and Multiple Sclerosis.
How to treat tumefactive demyelinating disease?
Merck KGaA to try again to get approval for MS pill cladribine
Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar Ataxia
Birth hospitalization in mothers with multiple sclerosis and their newborns.
Small Molecules in Stem Cell Research.
A population based cohort study to assess the safety of pandemic influenza vaccine Focetria(®) in Emilia-Romagna region, Italy-Part Two.
β-Lapachone ameliorization of experimental autoimmune encephalomyelitis.
AB Science announces successful non futility test for masitinib in progressive forms of multiple sclerosis
Phenytoin: an old but effective antiarrhythmic agent for the suppression of ventricular tachycardia.
Deafness in Patients with Multiple Sclerosis.

Pages